COVID‐19 vaccination hesitancy among people with chronic neurological disorders: A position paper
Open Access
- 10 May 2022
- journal article
- research article
- Published by Wiley in European Journal of Neurology
- Vol. 29 (8) , 2163-2172
Abstract
Background and purpose: Health risks associated with SARS‐CoV‐2 infection are undisputed. Moreover, the capability of vaccination to prevent symptomatic, severe, and fatal COVID‐19 is recognized. There is also early evidence that vaccination can reduce the chance for long COVID‐19. Nonetheless, the willingness to get vaccinated and receive booster shots remains subpar among people with neurologic disorders. Vaccine scepticism not only jeopardizes collective efforts to end the COVID‐19 pandemic but puts individual lives at risk, as some chronic neurologic diseases are associated with a higher risk for an unfavorable COVID‐19 course.Methods: In this position paper, the NeuroCOVID‐19 Task Force of the European Academy of Neurology (EAN) summarizes the current knowledge on the prognosis of COVID‐19 among patients with neurologic disease, elucidates potential barriers to vaccination coverage, and formulates strategies to overcome vaccination hesitancy. A survey among the Task Force members on the phenomenon of vaccination hesitancy among people with neurologic disease supports the lines of argumentation.Results: The study revealed that people with multiple sclerosis and other nervous system autoimmune disorders are most skeptical of SARS‐CoV‐2 vaccination. The prevailing concerns included the chance of worsening the pre‐existing neurological condition, vaccination‐related adverse events, and drug interaction.Conclusions: The EAN NeuroCOVID‐19 Task Force reinforces the key role of neurologists as advocates of COVID‐19 vaccination. Neurologists need to argue in the interest of their patients about the overwhelming individual and global benefits of COVID‐19 vaccination. Moreover, they need to keep on eye on this vulnerable patient group, its concerns, and the emergence of potential safety signals.Keywords
This publication has 62 references indexed in Scilit:
- Dementia and outcomes from coronavirus disease 2019 (COVID-19) pneumonia: A systematic review and meta-analysisArchives of Gerontology and Geriatrics, 2021
- A plea for equitable global access to COVID‐19 diagnostics, vaccination and therapy: The NeuroCOVID‐19 Task Force of the European Academy of NeurologyEuropean Journal of Neurology, 2021
- Primary prevention of COVID‐19: Advocacy for vaccination from a neurological perspectiveEuropean Journal of Neurology, 2021
- NeuroCOVID: it's time to join forces globallyThe Lancet Neurology, 2020
- Neurological comorbidity and severity of COVID-19Journal of Neurology, 2020
- Neurological Comorbidity Is a Predictor of Death in Covid-19 Disease: A Cohort Study on 576 PatientsFrontiers in Neurology, 2020
- Planning for a COVID-19 Vaccination ProgramJAMA, 2020
- The international European Academy of Neurology survey on neurological symptoms in patients with COVID‐19 infectionEuropean Journal of Neurology, 2020
- Cost-effectiveness of adult vaccinations: A systematic reviewVaccine, 2019
- Diagnosing the determinants of vaccine hesitancy in specific subgroups: The Guide to Tailoring Immunization Programmes (TIP)Vaccine, 2015